Additional file 1 of High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

Chao Hu (293389); Chao Liu (43092); Chaojie Wei (9758153); Chen Liang (196452); Cheng Tao (1546054); Chunmei Yun (12319787); Cunzi Yan (12424441); Fengfeng Lu (11398898); Han Zhang (110653); Hong Bi (1597333); Hong Luo (205745); Hong Teng (11239077); Hui Liu (33624); Hui Wei (126971); Jialin Liu (1732168); Jihua Zhang (1753450); Jingen Xia (4635955); Liqiong Zhang (6673793); Min Chen (147733); Mingyan Jiang (5825411); Pengguo Hou (12424447); Pinhua Pan (9426945); Qingyuan Zhan (3837055); Rongli Lu (5697535); Sichao Gu (12424438); Wei Lei (132543); Weiwei Gao (51947); Xu Huang (123594); Yang Yang (45629); Yanlei Ge (12424444); Yi Zhang (9093); Yingying Feng (136213); Yusheng Chen (158039); Zhenshun Cheng (9758156)

journal article text

Additional file 1 of High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

Abstract

Additional file 1. Table S1: Settings of treatment, vital sign, Borg scores, airway dryness score and blood gas analysis between the conventional oxygen therapy group and the high-flow nasal cannula group within 72 hours after randomization

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/19607...

Last time updated on 12/08/2022